Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
about
ABSL-4 aerobiology biosafety and technology at the NIH/NIAID integrated research facility at Fort DetrickEvaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model.Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpoxOrthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.Rabbitpox in New Zealand White Rabbits: A Therapeutic Model for Evaluation of Poxvirus Medical Countermeasures Under the FDA Animal Rule
P2860
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@ast
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@en
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@nl
type
label
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@ast
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@en
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@nl
prefLabel
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@ast
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@en
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@nl
P2860
P356
P1433
P1476
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.
@en
P2093
Chad J Roy
Thomas G Voss
P2860
P304
P356
10.3390/V2092096
P577
2010-09-01T00:00:00Z